Insider Transactions in Q1 2022 at Agios Pharmaceuticals, Inc. (AGIO)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 25
2022
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
108
-4.06%
|
$3,240
$30.0 P/Share
|
|
Feb 22
2022
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
59
-2.17%
|
$1,711
$29.08 P/Share
|
|
Feb 22
2022
|
Theodore James Washburn Jr. Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
167
+5.79%
|
-
|
|
Feb 22
2022
|
David P Schenkein Director |
SELL
Payment of exercise price or tax liability
|
Direct |
758
-0.65%
|
$21,982
$29.08 P/Share
|
|
Feb 22
2022
|
David P Schenkein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,775
+2.32%
|
-
|
|
Feb 22
2022
|
James William Burns Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
215
-1.43%
|
$6,235
$29.08 P/Share
|
|
Feb 22
2022
|
James William Burns Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
724
+4.6%
|
-
|
|
Feb 22
2022
|
Jacqualyn A Fouse Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,674
-4.68%
|
$106,546
$29.08 P/Share
|
|
Feb 22
2022
|
Jonathan Biller Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,688
-10.48%
|
$77,952
$29.08 P/Share
|
|
Feb 22
2022
|
Bruce Car Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,041
-10.86%
|
$59,189
$29.08 P/Share
|
|
Feb 22
2022
|
Richa Poddar Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
742
-14.32%
|
$21,518
$29.08 P/Share
|
|
Feb 22
2022
|
Richa Poddar Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
658
+11.27%
|
-
|
|
Feb 22
2022
|
Sarah Gheuens Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
955
-10.95%
|
$27,695
$29.08 P/Share
|
|
Feb 18
2022
|
Jacqualyn A Fouse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
12,379
+13.61%
|
-
|
|
Feb 18
2022
|
Jonathan Biller Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,523
+24.95%
|
-
|
|
Feb 18
2022
|
Bruce Car Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,874
+26.78%
|
-
|
|
Feb 18
2022
|
Richa Poddar Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,884
+29.4%
|
-
|
|
Feb 18
2022
|
Sarah Gheuens Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,271
+27.27%
|
-
|
|
Feb 16
2022
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
233
-8.38%
|
$6,990
$30.81 P/Share
|
|
Feb 14
2022
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Open market or private sale
|
Direct |
504
-15.34%
|
$15,624
$31.25 P/Share
|
|
Feb 14
2022
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
127
-3.72%
|
$3,810
$30.5 P/Share
|
|
Feb 14
2022
|
Theodore James Washburn Jr. Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
360
+9.54%
|
-
|
|
Feb 14
2022
|
Richa Poddar Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
590
-18.26%
|
$17,700
$30.5 P/Share
|
|
Feb 14
2022
|
Richa Poddar Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,738
+34.98%
|
-
|
|
Feb 14
2022
|
James William Burns Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,155
-13.11%
|
$64,650
$30.5 P/Share
|
|
Feb 14
2022
|
James William Burns Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,988
+18.83%
|
-
|
|
Feb 14
2022
|
Jacqualyn A Fouse Director |
SELL
Payment of exercise price or tax liability
|
Direct |
3,505
-5.03%
|
$105,150
$30.5 P/Share
|
|
Feb 14
2022
|
Jacqualyn A Fouse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
11,334
+13.99%
|
-
|
|
Feb 10
2022
|
Richa Poddar Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
725
-32.69%
|
$22,475
$31.43 P/Share
|
|
Feb 10
2022
|
Richa Poddar Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,068
+48.25%
|
-
|
|
Feb 10
2022
|
James William Burns Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
643
-6.37%
|
$19,933
$31.43 P/Share
|
|
Feb 10
2022
|
James William Burns Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,833
+15.37%
|
-
|
|
Feb 10
2022
|
Bruce Car Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,073
-8.26%
|
$33,263
$31.43 P/Share
|
|
Feb 10
2022
|
Bruce Car Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,667
+22.01%
|
-
|
|
Feb 10
2022
|
Jonathan Biller Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,349
-7.3%
|
$41,819
$31.43 P/Share
|
|
Feb 10
2022
|
Jonathan Biller Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,667
+16.57%
|
-
|
|
Feb 10
2022
|
Theodore James Washburn Jr. Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
273
-8.29%
|
$8,463
$31.43 P/Share
|
|
Feb 10
2022
|
Theodore James Washburn Jr. Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
777
+19.1%
|
-
|
|
Feb 10
2022
|
Sarah Gheuens Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
758
-12.21%
|
$23,498
$31.43 P/Share
|
|
Feb 10
2022
|
Sarah Gheuens Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,162
+25.82%
|
-
|
|
Jan 06
2022
|
Bruce Car Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,205
-11.44%
|
$38,560
$32.58 P/Share
|
|
Jan 06
2022
|
Bruce Car Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,437
+24.61%
|
-
|